Navigation Links
Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
Date:7/16/2008

DANBURY, Conn., July 16 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today announced that its two pivotal Phase III VIAject(TM) clinical trials are now complete, with the last study patient visit on July 14, 2008. Results of the full trial will be released either at Biodel's poster presentation at the European Association for the Study of Diabetes (EASD) on Tuesday, September 9, 2008, or at a later appropriate scientific forum.

Biodel also announced that two abstracts containing interim data from its VIAject(TM) Phase III clinical trials was posted on the Website for the 44th Annual Meeting of the EASD. The abstracts disclosed results of a January 2008 preliminary interim analysis of the secondary endpoints of dose, weight, and mild and moderate hypoglycemic events for the VIAject(TM) Phase III clinical trials.

"We continue to meet our timelines and are encouraged by the VIAject(TM) Phase III interim data, which continues to meet our expectations," stated Dr. Solomon Steiner, Chief Executive Officer and Chairman of Biodel. "We look forward to performing our final analysis and presenting data from the completed studies after the clinical trial database has been locked."

The interim analysis, dose and weight changes after six weeks of drug treatment were compared to the baseline for all patients who had completed six weeks or more of treatment. Additionally, total mild and moderate hypoglycemic events as of January 2008 were compared across the two treatment arms. The following additional information was reported in the EASD abstracts:

The interim results demonstrated statistically significant differences in weight changes in patients with Type 1 and Type 2 diabetes using VIAject(TM) compared to Humulin(R) R in the first six weeks of the study. Type 1 patients (n=102) receiving VIAject(TM) showed no change in weight compared to baseline, while a weight gain (1.4 +/- 2.9 kg) was seen in the patients (n=108) receiving Humulin(R
'/>"/>

SOURCE Biodel Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
2. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
3. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
4. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
5. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
6. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
7. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
8. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
9. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
10. Sosei Announces Completion of Phase III Trial for NorLevo(R)
11. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... Nov. 6 Keryx Biopharmac...ence call on Tuesday, November 10, 2009 at 8:30 a.... results and business outlook for the remainder of...e Company, will host the call. Keryx will announc... release to be issued prior to the call. ,, In ...
(Date:11/6/2009)..., Nov. 6 NexBio Inc., in collabora...ntrol and Prevention (CDC), St. Louis University, ...he publication of two articles in the peer-reviewe...uggest that DAS181 (Fludase ® ) may play a po...vention of the Pandemic Influenza A(H1N1) and drug...
(Date:11/5/2009)..., N.J., Nov. 5 Osteotech...field of biologic products for regenerative healin...quarter ended September 30, 2009. ,, "During th...ase of our three new biologic products MagniFuse(...d Plexur M® Innovative Grafting," said Sam Ow...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8US Oncology Inc Announces Issuance of 24775 Million of Debt Securities 49410 1US Oncology Inc Announces Issuance of 24775 Million of Debt Securities 49410 2Omega 3 Fatty Acids Might Curb Depression in Heart Patients 49408 1Omega 3 Fatty Acids Might Curb Depression in Heart Patients 49408 2Study Finds Possible Genetic Indicator of Colorectal Cancer 49406 1Study Finds Possible Genetic Indicator of Colorectal Cancer 49406 2
...g international experts on the,asbestos-related ca...ivers,loved ones and advocates to share the latest... Mesothelioma Applied Research Foundation,s,Intern... Thursday, June 26,- Saturday, June 28 at the Hyat...e Symposium, organized annually by the Meso Founda...
...8:30 a.m. EDT on May 29 -, SOMERSET, N.J., May 28...unced that the preliminary statistical analysis of...ial of its lead compound,ONCONASE (ranpirnase), di...y endpoint of survival in unresectable malignant m...icant improvement in survival was seen in,the trea...
Other Medicine Technology:International Symposium on Malignant Mesothelioma 2008 2Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial 2Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial 3Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial 4Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial 5
(Date:11/8/2009)...ealth Care Vote Shows Who Sides With Working Famil..., Nov. 8 On the heels o...esentatives for a good, balanced health care refor...ing of how our state,s U.S. representatives voted ... Act. ,, The legislation, which passed Saturda...
(Date:11/7/2009)...USTON, Nov. 7, The Amer...009 Benjamin Rush Award for Citizenship and Commun...ogist from Chicago, IL. The award recognizes physi...ional call of duty to make an outstanding public s...Kraff received the award today during the opening ...
(Date:11/7/2009)...SHINGTON, Nov. 7 With t...antichoice extremists are holding the entire bill ... are demanding that the bill go far beyond the sta...orporated into the original bill. In an outrageou...y Saturday afternoon, antichoice Democrats are dem...
(Date:11/7/2009)...O, Nov. 7 The Public Relations Society of America...low on Diane Gage Lofgren, senior vice president o... Permanente, tonight at a ceremony at PRSA,s 2009 ... inducted into the PRSA College of Fellows is one ...id Michael Herman, APR, SAGE, Fellow PRSA, and 200...
(Date:11/7/2009)... Forget ‘sweatox’ or &... UK is the usage of the anti-ageing jab ‘Bre...injected into the décolletage, can reduce t... chest area around the breasts, leaving smoother, ...PRWEB) November 7, 2009 -- Transform, the UK&rsquo...
Breaking Medicine News(10 mins):Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:UK Boobs Get a Boost with 'Breastox' 2
...of Pulse CO-Oximetry and Read-Through Motion and L...ion of CHN,s system-wide implementation of,Masimo ...y of superior,Masimo SET performance in other area...e for precise, continuous SpO2,monitoring. "The d...
...ue in children suggests that,altering timing or do...on,sleep and increase quality of life for patients...anti-leukemia,drug dexamethasone contributes to a .... Jude Children,s Research Hospital.,The finding s...
...h professionals will meet in Washington, D.C., Nov...on,s most pressing public health issues at the,Ame...ual Meeting., The five-day meeting of more than 1...licy-makers from around the,world., Press interes...
...Nov. 1, Warner Chilcott Company, Inc. (a subsidiar...xMed, Inc. (Nasdaq: NEXM ),announced today that t...eement granting Warner Chilcott the exclusive U.S....he Food and,Drug Administration on September 21, 2...
.... (Nasdaq: DATA ), a technology and services comp...clinical trials industry, today announced that,it ...er and nine month,operating results at 4:30 p.m. E...nce call will also be available,via live web cast ...
... Scientific Sessions 2007, Press Breakfast, ORLA...y Itamar Medical:, WHO: Dr. Amir Lerman, P...ochester, MN Dr. Peter Friberg, Sahlg...Pritzker, Cardiologist, University of Minnesota ...
Other Medicine News:Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Health News:St. Jude Finds Anti-Leukemia Drug Increases Patient Fatigue 2Health News:14,000 Public Health Experts to Convene at American Public Health Association Annual Meeting in Washington, D.C. 2Health News:14,000 Public Health Experts to Convene at American Public Health Association Annual Meeting in Washington, D.C. 3Health News:Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction 2Health News:Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction 3Health News:Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction 4Health News:DATATRAK International Management To Host Conference Call on November 8, 2007 To Discuss Third Quarter and Nine Month Operating Results for 2007 2Health News:DATATRAK International Management To Host Conference Call on November 8, 2007 To Discuss Third Quarter and Nine Month Operating Results for 2007 3Health News:How Early Can We Detect Cardiovascular Disease Less Expensively... Even in Childhood? 'PAT' is the Invisible Signal 2
...older™ Platform is designed with a spring-lo...d E-Gel® 48 gel cassettes stay firmly in place...placement and loading from one gel to the next wit...ng software. In addition, the E-Holder™ Plat...
... units can be used for: Analytical Protein and Pep...ng SDS-PAGE gels IEF in ultrathin PAGE gels (Z64,0...d Peptide Separation: Non-denaturating PAGE gels a...,071-9& Z64,075-1) Molecular Biology: DNA/RNA frag...
... set up and safe to use, the Gel XL Ultra includes...agarose gels. The unit is compact, requiring a min...er supply eliminates a tangled mess of leads and c...fety and convenience, the power supply can detect ...
...i-Chameleon has a centimeter ruler etched into the...cludes apparatus, connecting cables, three 7x10 cm...and three 14-well combs. The Chameleon can accomod...lectrophoresis of a maximum of 120 samples with a ...
Medicine Products: